Concepedia

Author

Ronda Rippley

United States Military Academy

Also Known As

R Rippley, R. Rippley, R.K. Rippley, Ronda K Rippley, Ronda K. Rippley, Ronda Rippley

30

Publications

289

Citations

10

H-Index

31

Concepts

All Affiliations

United States Military AcademyRegeneron (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Rainbow Babies & Children's HospitalCase Western Reserve University
RR

About

Ronda Rippley is an author at United States Military Academy specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

120

2

Health Sciences

2

2

40

3

Biochemistry

1

1

23

4

Diabetes

1

1

17

5

Endocrinology

1

1

17

Ronda Rippley

×

11

Publications

251

Citations

10

H-Index

YearCitations

The Pharmacokinetics of Enalapril in Children and Infants with Hypertension

Thomas G. Wells, Ronda Rippley, Ronald J. Hogg,

The Journal of Clinical Pharmacology

2001

56

A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension

Ronald J. Hogg, Ángela Delucchi, Graciela Sakihara,

Pediatric Nephrology

2007

31

Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignancies

Feng Yang, Anne Paccaly, Ronda Rippley,

Journal of Pharmacokinetics and Pharmacodynamics

2021

28

Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters

Xiaoyan Chu, Yuexia Liang, Xiaoxin Cai,

Pharmaceutical Research

2008

23

Effects of cellular pharmacology on drug distribution in tissues

Ronda Rippley, Cynthia L. Stokes

Biophysical Journal

1995

21

A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study of the Pharmacokinetics and Pharmacodynamics of REGN3918, a Human Antibody Against Complement Factor C5, in Healthy Volunteers

Jonathan Weyne, Ni Yan, Richard DelGizzi,

Blood

2018

19

Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data

Pavel Kovalenko, John D. Davis, Meng Li,

Clinical Pharmacology in Drug Development

2020

19

A Dual PPAR ??/?? Agonist Increases Adiponectin and Improves Plasma Lipid Profiles in Healthy Subjects

Katelijn Decochez, Ronda Rippley, Jutta Miller,

Drugs in R&D

2006

17

Pharmacokinetic assessment of an oral enalapril suspension for use in children

Ronda Rippley, John D. Connor, Janet Boyle,

Biopharmaceutics & Drug Disposition

2000

15

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis

Anne Paccaly, Michael R. Migden, Kyriakos P. Papadopoulos,

Advances in Therapy

2021

12

Page 1